(Incorporated in
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", or the "Company", or the "Group")
23
ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING POLL RESULTS
Mediclinic announces that at its Annual General Meeting ("AGM"), held on
Results of poll
|
|
Total Shares Voted
|
% of Issued Share Capital Voted3
|
Votes For1
|
%
|
Votes Against
|
%
|
Votes Withheld2
|
|
Ordinary Resolutions |
|
|
|
|
|
|
|
1. |
To receive the Company's financial statements and the reports of the directors and auditor |
651 029 501 |
88.31 |
650 973 436 |
99.99 |
56 065 |
0.01 |
765 665 |
2. |
To approve the Directors' Remuneration Report |
649 411 121 |
88.09 |
644 127 734 |
99.19 |
5 283 387 |
0.81 |
2 384 045 |
3. |
To approve the Directors' Remuneration Policy |
651 380 968 |
88.35 |
633 886 281 |
97.31 |
17 494 687 |
2.69 |
414 198 |
4. |
To elect Dame |
651 404 426 |
88.36 |
651 387 915 |
100.00 |
16 511 |
0.00 |
390 741 |
5. |
To elect Mr |
651 404 426 |
88.36 |
650 720 860 |
99.90 |
683 566 |
0.10 |
390 741 |
6. |
To re-elect Dr |
651 409 511 |
88.36 |
650 544 510 |
99.87 |
865 001 |
0.13 |
385 656 |
7. |
To re-elect Mr |
651 405 217 |
88.36 |
650 346 872 |
99.84 |
1 058 345 |
0.16 |
389 950 |
8. |
To re-elect Mr |
651 405 241 |
88.36 |
650 718 418 |
99.89 |
686 823 |
0.11 |
389 926 |
9. |
To re-elect Dr Muhadditha Al Hashimi as a director |
651 408 721 |
88.36 |
650 760 951 |
99.90 |
647 770 |
0.10 |
386 446 |
10. |
To re-elect Mr |
651 405 784 |
88.36 |
615 278 225 |
94.45 |
36 127 559 |
5.55 |
389 383 |
11. |
To re-elect Dr |
651 405 217 |
88.36 |
650 754 844 |
99.90 |
650 373 |
0.10 |
389 950 |
12. |
To re-elect Mr |
651 405 661 |
88.36 |
642 412 072 |
98.62 |
8 993 589 |
1.38 |
389 506 |
13. |
To re-elect Dr |
651 409 091 |
88.36 |
650 761 951 |
99.90 |
647 140 |
0.10 |
386 076 |
14. |
To re-elect Mr |
651 409 090 |
88.36 |
642 489 636 |
98.63 |
8 919 454 |
1.37 |
386 076 |
15. |
To re-appoint |
651 405 420 |
88.36 |
648 862 581 |
99.61 |
2 542 839 |
0.39 |
389 747 |
16. |
To authorise the |
651 405 369 |
88.36 |
651 393 310 |
100.00 |
12 059 |
0.00 |
389 798 |
17. |
To authorise the directors to make political donations |
651 424 227 |
88.36 |
544 059 407 |
83.52 |
107 364 820 |
16.48 |
370 940 |
18. |
To authorise the directors to allot ordinary shares |
651 422 134 |
88.36 |
518 848 733 |
79.65 |
132 573 401 |
20.35 |
373 033 |
|
Special Resolutions |
|
|
|
|
|
|
|
19. |
To authorise the directors to dis-apply statutory pre-emption rights |
651 402 291 |
88.36 |
535 602 120 |
82.22 |
115 800 171 |
17.78 |
392 876 |
20. |
To authorise the directors to dis-apply pre-emption rights for purposes of acquisitions or capital investments |
651 402 432 |
88.36 |
551 523 823 |
84.67 |
99 878 609 |
15.33 |
392 734 |
21. |
To approve the calling of general meetings on not less than 14 days' clear notice (other than AGMs) |
651 420 376 |
88.36 |
607 406 150 |
93.24 |
44 014 226 |
6.76 |
374 791 |
22. |
To adopt the new Articles of |
651 382 529 |
88.35 |
651 229 816 |
99.98 |
152 713 |
0.02 |
412 638 |
Votes of shareholders excluding the controlling shareholder, Remgro Limited4, on the election and re-election of independent non-executive directors
|
Ordinary Resolutions |
Total Shares Voted |
% of Issued Share Capital Voted3 |
Votes For1 |
% |
Votes Against |
% |
Votes Withheld2 |
4. |
To elect Dame |
322 906 538 |
79.00 |
322 890 027 |
99.99 |
16 511 |
0.01 |
390 741 |
5. |
To elect Mr |
322 906 538 |
79.00 |
322 222 972 |
99.79 |
683 566 |
0.21 |
390 741 |
8. |
To re-elect Mr |
322 907 353 |
79.00 |
322 220 530 |
99.79 |
686 823 |
0.21 |
389 926 |
9. |
To re-elect Dr Muhadditha Al Hashimi as a director |
322 910 833 |
79.00 |
322 263 063 |
99.80 |
647 770 |
0.20 |
386 446 |
11. |
To re-elect Dr |
322 907 329 |
79.00 |
322 256 956 |
99.80 |
650 373 |
0.20 |
389 950 |
13. |
To re-elect Dr |
322 911 203 |
79.00 |
322 264 063 |
99.80 |
647 140 |
0.20 |
386 076 |
14. |
To re-elect Mr |
322 911 202 |
79.00 |
313 991 748 |
97.24 |
8 919 454 |
2.76 |
386 076 |
Notes:
1. |
Any proxy appointments giving discretion to the Chair of the AGM have been included in the "For" total.
|
2. |
A vote "Withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
|
3. |
The Company's total ordinary shares in issue (total voting rights) as at
|
4. |
As the Company has a controlling shareholder, Remgro Limited, as defined in the Financial Conduct Authority's Listing Rules, each resolution to elect an independent non-executive director (Resolutions 4, 5, 8, 9, 11, 13 and 14) have under Listing Rule 9.2.2E been approved by a majority of the votes cast by: (a) the shareholders of the Company as a whole; and (b) the independent shareholders of the Company, that is, all the shareholders entitled to vote on each resolution, excluding the controlling shareholder. |
Statement regarding voting results
The Board notes that while Resolution 18 was passed with a majority of 79.65%, a number of our shareholders opposed that resolution. The Board notes that the voting outcome reflects the differing market practice between the
A copy of the special resolutions and certain ordinary resolutions affecting the Company's constitution which were passed at the meeting will shortly be submitted to the National Storage Mechanism in accordance with paragraph 9.6.2 of the Listing Rules. In addition, the Company will submit to the National Storage Mechanism a copy of its Articles of Association dated
About
Mediclinic is a diversified international private healthcare services group, established in
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
At
The Company's primary listing is on the
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the
For further information, please contact:
Company Secretary,
+44 (0)20 7954 9548
Investor Relations,
+44 (0)20 3786 8181
Media queries
FTI Consulting
+44 (0)20 3727 1000
+27 (0)21 487 9000
Registered address: 6th Floor,
Website: www.mediclinic.com
Corporate broker (
JSE sponsor (
NSX sponsor (
This information is provided by RNS, the news service of the